Michael Thomas Henderson, Chief Executive Officer at Apogee Therapeutics, Inc. (APGE), sold 15,000 shares at $59.17 ($888K) on 2024-11-06, disclosed to the SEC on 2024-11-08.
Scheduled sale ($888k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.17 | 14,000 | $828K | 93.3% |
| 2 | $59.94 | 1,000 | $60K | 6.7% |
| Total | $59.22 avg | 15,000 | $888K | 100% |
| Filing → |
| SYRE | SELL | 2026-06-23 | $2.0M | — | Filing → |
| APGE | SELL | 2026-06-12 | $1.7M | — | Filing → |
| APGE | SELL | 2026-05-15 | $1.6M | — | Filing → |